Transcatheter repair cuts death, HF hospitalization in severe tricuspid regurgitation

MUNICH — A strategy of transcatheter tricuspid valve repair on top of optimal medical therapy was superior to medical therapy alone for patients with symptomatic severe tricuspid regurgitation and heart failure, according to new data. In addition to improvements in quality of life previously seen in tricuspid valve repair trials, the interventional was associated with meaningful reductions